Long-term treatment of hypercholesterolemia with fluvastatin: A 52-week multicenter safety and efficacy study

This publication has 12 references indexed in Scilit:

• Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
  JAMA, 1993
• Pharmacokinetics of Fluvastatin After Single and Multiple Doses in Normal Volunteers
  The Journal of Clinical Pharmacology, 1992
• Summarizing Laboratory Data with Different Reference Ranges in Multi-Center Clinical Trials
  Drug Information Journal, 1992
• A Comparative Review of the Adverse Effects of Treatments for Hyperlipidaemia
  Drug Safety, 1991
• HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels.
  Circulation, 1989
• A selective bi-site immunoenzymatic procedure for human Lp[a] lipoprotein quantification using monoclonal antibodies against apo[a] and apoB.
  Journal of Lipid Research, 1989
• UNCHANGED SERUM LIPOPROTEIN (A) CONCENTRATIONS WITH LOVASTATIN
  The Lancet, 1989
• Lovastatin
  Drugs, 1988
• Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor
  Journal of Molecular Medicine, 1988
• Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge
  Clinical Chemistry, 1972